New Clinical Guideline for Arthritis Pain

Published Online: Wednesday, May 1, 2002

The American Pain Society (APS), the leading US professional organization devoted to pain management, recently released the first evidence-based, multidisciplinary guideline for treating acute and chronic arthritis pain.

The full text of the APS guideline is available at arthritis.htm. It strongly emphasizes that arthritis pain is best treated through a combination of ongoing pain assessment, medication, proper nutrition, exercise, and patient and family education.

? For mild-to-moderate pain?acet-aminophen is the drug of choice because of its mild side effects, wide availability, and low cost.
? For moderate-to-severe pain?cyclooxygenase-2 (COX-2) non-steroidal anti-inflammatory drugs (NSAIDs), such as Celebrex and Vioxx, are the drugs of choice for their pain-relieving potency and absence of gastrointestinal (GI) side effects.
? If the patient fails to respond to acetaminophen and COX-2 drugs, nonselective NSAIDs should be considered, but only if the patient is not at risk for NSAID-induced GI side effects.
? For severe arthritis pain for which COX-2 drugs and nonspecific NSAIDs do not provide substantial relief, opioid medications, such as oxycodone and morphine, are recommended

Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues